Search

everythinglearnresearchcommunity

for

Search:↓

Enzymes play crucial roles in metabolism, health, and disease management.

Latanoprost may cause scalp inflammation and delayed healing.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Two young siblings experienced hair loss without hormone issues or other skin problems.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

The article concludes that early diagnosis and lifestyle changes can prevent complications from high uric acid levels.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Topical JAK inhibitors may help treat some skin conditions but need more research.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.